UNC has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

image2
Drawing blood samples at the Kanyama Clinic in Lusaka, Zambia. Lusaka is one of five sites in the new Global HIV/AIDS Prevention and Treatment Clinical Trials Unit. Photo: Jorge Alberto Perez

Media Contact: Lisa Chensvold, 919-843-5719,

Wednesday, February 26, 2014

The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

The Global HIV Prevention and Treatment Clinical Trials Unit (UNC Global CTU) is led by three co-principal investigators from the UNC School of Medicine: Joseph Eron, MD, professor of medicine; Jeffrey Stringer, MD, professor of obstetrics and gynecology; and Mina Hosseinipour, MD, MPH, professor of medicine. The CTU is housed in the UNC Institute for Global Health & Infectious Diseases.

Read entire story….